Cardiovasc Res
Research & Early Development, Cardiovascular, Renal and Metabolic Diseases (CVRM), Biopharmaceuticals R&D, AstraZeneca, 431 83 Mölndal, Sweden.
Published: December 2019
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!
© LitMetric 2025. All rights reserved.